Keytruda® Approved for Small Cell Lung Cancer - DocWire News
Keytruda® Approved for Small Cell Lung Cancer DocWire News
The Food and Drug Administration (FDA) has granted approval for Keytruda® (pembrolizumab) to treat metastatic small cell lung cancer (SCLC).
Comments
Post a Comment